Equillium, Inc. (EQ) vs PMV Pharmaceuticals, Inc. (PMVP)

Equillium, Inc. and PMV Pharmaceuticals, Inc. are both Biotechnology companies. Equillium, Inc. and PMV Pharmaceuticals, Inc. are of similar size ($95.1M and $94.4M). Across the 9 metrics below, Equillium, Inc. leads on 6 and PMV Pharmaceuticals, Inc. on 3.

Valuation

Metric EQ PMVP Biotechnology median
P/E n/m n/m 10.96
P/S 4.00 n/m 9.52
P/B 2.93 0.92 2.23
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m 0.17 0.68
EV/Sales 2.79 n/m 9.00
Earnings yield (13.61%) (115.45%) (32.09%)
Free cash flow yield (12.22%) (108.52%) (22.62%)

Profitability

Metric EQ PMVP Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (58.98%) (70.93%) (50.12%)
Return on assets (50.68%) (64.04%) (45.12%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EQ PMVP Biotechnology median
Revenue growth (TTM) 13.89% — 6.78%
EPS growth (last fiscal year) (69.57%) (29.82%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EQ PMVP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 23.40 7.70 4.74
Net debt to EBITDA 1.29 1.27 1.01

Dividend

Metric EQ PMVP Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric EQ PMVP Biotechnology median
Market cap 95.12m 94.39m 166.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack